Loading...
Header Logo
Keywords
Last Name
Institution

MICHELLE SIBILLE

TitleInstructor
InstitutionBaylor College of Medicine
DepartmentDepartment of Medicine
DivisionMedicine-General Med/VAMC
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Sibille M, Patat A, Caplain H, Donazzolo Y. A safety grading scale to support dose escalation and define stopping rules for healthy subject first-entry-into-man studies: some points to consider from the French Club Phase I working group. Br J Clin Pharmacol. 2010 Nov; 70(5):736-48. PMID: 21039768.
      View in: PubMed
    2. Sibille M, Donazzolo Y, Lecoz F, Krupka E. After the London tragedy, is it still possible to consider Phase I is safe? Br J Clin Pharmacol. 2006 Oct; 62(4):502-3. PMID: 16817849.
      View in: PubMed
    3. Paccaly A, Ozoux ML, Chu V, Simcox K, Marks V, Freyburger G, Sibille M, Shukla U. Pharmacodynamic markers in the early clinical assessment of otamixaban, a direct factor Xa inhibitor. Thromb Haemost. 2005 Dec; 94(6):1156-63. PMID: 16411387.
      View in: PubMed
    SIBILLE's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description